Kornelia Polyak, M.D., Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Kornelia Polyak, M.D., Ph.D., Dana-Farber Cancer Institute

Caption

Kornelia Polyak, M.D., Ph.D., a breast cancer geneticist at Dana-Farber Cancer Institute, and colleagues report that they have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.

Credit

Sam Ogden.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.